JUSTINE UNRUH: Open Payments
NPI 1154840098 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 78 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $236 |
| Madrigal Pharmaceuticals | 8 | $231 |
| Janssen Biotech, Inc. | 9 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| Lilly USA, LLC | 5 | $110 |
| Aimmune Therapeutics, Inc. | 6 | $94 |
| GENZYME CORPORATION | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $68 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, RINVOQ, XIFAXAN, OMVOH, EOHILIA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
